Download Citation
Article Source:
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Cottu PH,
Bonneterre J,
Varga A,
Campone M,
Leary A,
et al.
(2018)
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
PLOS ONE 13(10): e0204973.
https://doi.org/10.1371/journal.pone.0204973